In vivo assessment of the drug interaction between sorafenib and paracetamol in rats
Sign Up to like & getrecommendations! Published in 2020 at "Cancer Chemotherapy and Pharmacology"
DOI: 10.1007/s00280-020-04075-3
Abstract: Purpose Sorafenib is a multi-targeted tyrosine kinase inhibitor (TKI) used for the treatment of advanced renal cell carcinoma, hepatocellular carcinoma and radioactive iodine resistant thyroid carcinoma. Neoplastic diseases are the cause of pain, which may… read more here.
Keywords: drug; group received; paracetamol; sorafenib paracetamol ... See more keywords